The $8.3 billion acquisition of the California drug maker will bring a respiratory treatment drug under Swiss buyer's banner.
Japanese drugmaker Chugai Pharmaceutical sees its stock rise, despite strenuous denials that its majority shareholder Roche wants to take it private.
Saab owner National Electric Vehicle Sweden admitted it didn't have enough cash to pay suppliers but said it wasn't yet insolvent.
Germany's Deutsche Telekom obliquely confirmed that it had rejected an unsolicited takeover proposal for its T-Mobile US unit from French cellular upstart Iliad.
Sprint reportedly drops discussions with T-Mobile US about acquiring the company.
Sprint on Tuesday appointed Marcelo Claure as the company's new CEO and indicated it would end its run at T-Mobile USA.
Germany's Siemens on Tuesday agrees to sell its hospital information systems division to Cerner for $1.3 billion.
Spain's Telefonica on Tuesday offered to by Brazilian phone company GVT from French media company Vivendi for $8.9 billion.
Australian winemaker Treasury Wine Estates said it would enter talks to be bought by Kohlberg Kravis Roberts & Co. and Rhone Capital.
Hedge fund Elliott Management is believed to be the plaintiff in a lawsuit over the $10.4B merger.